Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2022

View Archived Issues

Discovery of novel orally active FXR agonist with improved potency

Researchers present a promising approach for efficient solid tumor cell killing

Discovery of novel antioxidant, antiedematogenic and antinociceptive compound

New York Blood Center patents new antiviral compounds

Hanmi Science divulges new EZH inhibitors

Medshine Discovery discloses new S1PR1 agonists

Betta Pharmaceuticals presents YAP1 or TAZ/TEAD interaction inhibitors

Sunshine Lake Pharma identifies new GTPase KRAS mutant inhibitors

Osmolytes induce kidney EMT

Small Pharma eyes clinic with DMT candidate SPL-028

Aligos advances early-stage programs

Viridian Therapeutics offers update on nonclinical pipeline

Researchers suggest IL-33R modulation for controlling lung inflammation and pulmonary fibrosis

STK-002 enters preclinical toxicology studies for autosomal dominant optic atrophy

Oncternal advances ONCT-808 toward IND filing and ONCT-534 into IND-enabling studies

AEterna Zentaris expands research agreement with JMU to support COVID-19 and Chlamydia vaccines

Morningside Ventures launches Adiso Therapeutics focused on inflammatory diseases

Poseida Therapeutics reports progress across nonclinical programs

Sensei advances preclinical pipeline based on TMAb and ImmunoPhage platforms

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...